Neuropilin-1 identifies endothelial precursors in human and murine embryonic stem cells before cd34 expression

Circulation

Volumn 119, Issue 16, 2009, Pages 2170-2178

  Cimato, Thomas ^a,b   Beers, Jeanette ^a   Ding, Shunli ^b   Ma, Mingchao ^b   McCoy, J Phillip ^b   Boehm, Manfred ^b   Nabel, Elizabeth G ^a,b  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

endothelium; Stem cells; Vascular biology; Vasculogenesis

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; NEUROPILIN 1; SEMAPHORIN; VASCULOTROPIN RECEPTOR 2; BIOLOGICAL MARKER; BRACHYURY PROTEIN; FETOPROTEIN; T BOX TRANSCRIPTION FACTOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL CULTURE; CELL DIFFERENTIATION; CELL POPULATION; CELL SELECTION; COMPARATIVE STUDY; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; CELL LINE; CULTURE MEDIUM; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; IN VITRO STUDY; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD31; ANTIGENS, CD34; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINE; CULTURE MEDIA, SERUM-FREE; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; FETAL PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROPILIN-1; SEMAPHORINS; T-BOX DOMAIN PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 66549111659     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.849596     Document Type: Article

References (22)

1. Drake CJ. Embryonic and adult vasculogenesis. Birth Defects Res C Embryo Today. 2003;69:73-82.
2. Jakobsson L, Kreuger J, Claesson-Welsh L. Building blood vessels-stem cell models in vascular biology. J Cell Biol. 2007;117:751-755.
3. Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yuruqi T, Naito M, Nakao K, Nishikawa S. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature. 2000;408: 92-96.
4. Fehling HJ, Lacaud G, Kubo A, Kennedy M, Robertson S, Keller G, Kouskoff V. Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development. 2003;130:4217-4227.
5. Sone M, Itoh I, Yamahara K, Yamahara K, Yamashita JK, Yurugi- Kobayashi T, Nonoguchi A, Suzuki Y, Chao T-H, Sawada N, Fukunaga Y, Miyashita K, Park K, Oyamada N, Sawada N, Taura D, Tamura N, Kondo Y, Nito S, Suemori H, Nakatsuji N, Nishikawa S-I, Nakao K. Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Atheroscler Thromb Vasc Biol. 2007;27:2127-2134.
6. Levenberg S, Zoldan J, Basevitch Y, Langer R. Endothelial potential of human embryonic stem cells. Blood. 2007;110:806-814.
7. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice. Nature. 1995;376:62-66.
8. Staton CA, Kumar I, Reed MWR, Brown NJ. Neuropilins in physiological and pathological angiogenesis. J Pathol. 2007;212:237-248.
9. Takashima S, Kitakaze M, Asakura M, Asanuma H, Sanada S, Tashiro F, Niwa H, Miyazaki JJ, Hirota S, Kitamura Y, Kitsukawa T, Fujisawa H, Klagsbrun M, Hori M. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc Natl Acad Sci. 2002;99:3657-3662.
10. Ying QL, Nichols J, Chambers I, Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell. 2003;115:281-292.
11. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145-1147.
12. Kattman SJ, Huber TL, Keller GM. Multipotent flk-1 + cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell. 2006;11:723-732.
13. Kennedy M, D'Souza SL, Lynch-Kattman M, Schwantz S, Keller G. Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood. 2007;109:2679-2687.
14. Liang WC, Dennis MS, Stawicki S, Chanterhy Y, Pan Q, Chen Y, Eigenbrot C, Yin J, Koch AW, Wu X, Ferrara N, Bargi A, Tessier- Lavigne M, Watts RJ, Wu Y. Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library. J Mol Biol. 2007;366:815-829.
15. Park C, Afrikanova I, Chung YS, Zhang WJ, Arentson E, Fong G, Rosendahl A, Choi K. A hierarchical order of factors in the generation of FLK1- and SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells. Development. 2004;131:2749-2756.
16. Davidson AJ, Ernst P, Wang Y, Dekens MP, Kingsley PD, Palis J, Korsmeyer SJ, Daley GQ, Zon LI. Cdx4 mutants fail to specify blood progenitors and can be rescued by multiple hox genes. Nature. 2003;425: 300-306.
17. Gering M, Yamada Y, Rabbitts TH, Patient RK. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1. Development. 2003;130: 6187-6199.
18. Lee P, Goishi K, Davidson AJ, Mannix R, Zon L, Klagsbrun M. Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish. Proc Natl Acad Sci U S A. 2002;99:10470-10475.
19. Miao HQ, Lee P, Lin H, Soker S, Klagsbrun M. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J. 2000;14:2532-2539.
20. Roskoski R. Vascular endothelial growth factor signaling in tumor progression. Crit Rev Oncol Hematol. 2007;62:179-213.
21. Pan Q, Chanthery Y, Lian W-C, Stawicki S, Mak J, Rathore N, Tong RK, Kowalski J, Fong Yee S, Pacheco G, Ross S, Cheng Z, Le Couter J, Plowman G, Peale F, Koch AW, Wu Y, Bagri A, Tessier-Lavigne M, Watts RJ. Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer Cell. 2007;11:53-67.
22. Chittenden TW, Claes F, Lanahan AA, Autiero M, Palac RT, Tkachenko EV, Elfenbein A, Ruiz de Almodovar C, Dedkov E, Tomanek R, Li W, Westmore M, Singh JP, Horowitz A, Mulligan-Kehoe MJ, Moodie KL, Zhuang ZW, Carmeliet P, Simons M. Selective regulation of arterial branching morphogenesis by synectin. Dev Cell. 2006;10:783-795.